Company Executives

$CHRS Management Team

Ms. Jami Taylor

Head of Investor Relations

Age -

Compensation -

Sex Female

Mr. Dennis Lanfear

Chairman of the Board

President

Chief Executive Officer

Age 69

Compensation $4.802M USD

Sex Male

Dr. Theresa Lavallee

Chief Development Officer

Age 53

Compensation -

Sex Female

Mr. Bryan Mcmichael

Chief Financial Officer

Age 46

Compensation $1.033M USD

Sex Male

Name / Title	Age	Compensation	Sex
Ms. Jami Taylor Head of Investor Relations	-	-	Female
Mr. Dennis Lanfear Chairman of the Board President Chief Executive Officer	69	$4.802M USD	Male
Dr. Theresa Lavallee Chief Development Officer	53	-	Female
Mr. Bryan Mcmichael Chief Financial Officer	46	$1.033M USD	Male

Board of Directors

From the proxy statement filed Apr 20, 2026

Directors

serving now

Independent

2 of 3

stated in the proxy; 6 not stated

Average tenure

6.8 years

from year joined

CEO also chairs the board

Yes

Dennis M. Lanfear

Director	Age	On board	Independent	Committees	Other public boards	Pay
Rita A. Karachun	62	2024 2 years	Not stated	Audit Committee · Chair	None stated	Not stated
Lee N. Newcomer, MD	74	2022 4 years	Not stated	Compensation Committee	Myriad Genetics, Inc., Cellworks Group Inc.	Not stated
Charles W. Newton	55	2022 4 years	Not stated	Compensation Committee · Chair	Novavax, Inc., Keros Therapeutics	Not stated
Jill O’Donnell-Tormey, Ph.D.	70	2022 4 years	Not stated	Nominating and Corporate Governance Committee	None stated	Not stated
Michael Ryan	71	2023 3 years	Not stated	Compensation Committee	None stated	Not stated
Ali J. Satvat	48	2014 12 years	Not stated	Nominating and Corporate Governance Committee · Chair	BridgeBio Pharma, Inc.	Not stated
Georgia Erbez Leaving at the meeting	59	2024 2 years	Independent	Audit Committee	None stated	Not stated
Dennis M. Lanfear Board chair, CEO	70	2010 16 years	Not independent	None stated	None stated	Paid as CEO
Mats L. Wahlström	71	2012 14 years	Independent	Audit Committee Nominating and Corporate Governance Committee	Triomed AB, TriSalus Lifesciences Inc., Caduceus Medical Holdings, Inc., Circuit Clinical Solutions, Inc.	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 20, 2026 states there were none.

Read it in the proxy

Comments